Abstract
The progressive course of hepatic encephalopathy developing in rats after massive hepatic ischemia due to hepatic artery ligation within 48 hr of a portacaval shunt was not altered by the injection of a benzodiazepine antagonist, CGS 8216, in a dose that was sufficient to reverse diazepam-induced coma quickly. The onset of hepatic coma was shortened 20 to 25% by the antagonist, rather than being delayed, as would be expected if hepatic coma were due to a γ-aminobutyric acid (GABA)-ergic effect. The neural binding of GABA by brains from rats in deep hepatic coma was unaffected by the injection of the benzodiazepine antagonist.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baraldi, M., and Zeneroli, M. L. (1982). Experimental hepatic encephalopathy: Changes in γ-aminobutyric acid.Science 216: 427–431.
Baraldi, M., Zeneroli, M. L., Ventura, E.,et al. (1984a). Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: Reversal by a benzodiazepine antagonist.Clin. Sci. 67: 167–175.
Baraldi, M., Zeneroli, M. L., Ventura, E.,et al. (1984b). Port-systemic encephalopathy in dogs: Changes in brain GABA receptors and neurochemial correlates. In Kleinberger, G., Ferenci, P., Riederer, P., and Thaler, H. (eds.),Advances in Hepatic Encephalopathy and Urea Cycle Diseases, S. Karger, Basel, pp. 353–359.
Baraldi, M., Pinelli, G., Ricci, P., and Zeneroli, M. L. (1984c). Toxins in hepatic encephalopathy: The role of the synergistic effect of ammonia, mercaptans and short chain fatty acids.Arch. Toxicol. Suppl. 7: 103–105.
Bassett, M. L., Mullen, K. D., Skolnick, P., and Jones, E. A. (1985). GABA and benzodiazepine receptor antagonists ameliorate hepatic encephalopathy in a rabbit model of fulminant hepatic failure.Hepatology 5: 1032.
Ferenci, P., Pappas, S. C., Munson, P. J., Henson, K., and Jones, E. A. (1984). Changes in status of neurotransmitter receptors in a rabbit model of hepatic encephalopathy.Hepatology 4: 186–191.
Ferenci, P., Zieve, L., Ebner, J., Zimmermann, Ch., and Rzepczynski, D. (1986a). Postsynaptic neural membrane affinity for GABA and receptor density are unaltered in hepatic coma following portacaval shunt and hepatic artery ligation.Hepatology 6: 1143.
Ferenci, P., Zimmermann, Ch., and Ebner, J. (1986b). Thioacetamide acute liver failure in the rat—a suitable model for hepatic encephalopathy?J. Hepatol. 3 (Suppl. 1): 121.
Ferenci, P., Zieve, L., Ebner, J., Zimmermann, Ch., and Rzepczynski, D. (1987). Postsynaptic γ-aminobutyric acid receptors in hepatic coma following portacaval shunt and hepatic artery ligation in the rat.Metab. Brain Dis. 2: 195–200.
Maddison, J. E., Dodd, P. R., Johnston, G. A. R., and Farrell, G. C. (1987). Brain GABA receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma GABA-like activity.Gastroenterology 92 (in press).
Rzepczynski, D., Zieve, L., Lindblad, S., and LaFontaine, D. (1986). In vivo studies of GABAergic effects in experimental hepatic encephalopathy.Hepatology 6: 902–905.
Schafer, D. F., Fowler, J. M., Munson, J. P., Thakur, A. K., Waggoner, J. G., and Jones, E. A. (1983). Gamma-amino-butyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure.J. Lab. Clin. Med. 102: 870–880.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zieve, L., Ferenci, P., Rzepczynski, D. et al. A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural γ-aminobutyric acid (GABA) binding. Metabolic Brain Disease 2, 201–205 (1987). https://doi.org/10.1007/BF00999611
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00999611